Medicus Pharma Stock
Medicus Pharma Ltd. Common Stock
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Canada
- CEO
- Raza Bokhari
- Employees
- 16
- Market cap
- $5 M
- IPO
- 15/11/2024
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological…
Medicus Pharma stock: price history
1D
-5.2%
1W
-29.5%
1M
-58.4%
6M
-81.5%
YTD
-95.8%
1Y
-97.3%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
13/11/2026 (in 27 days)
Volatility around earnings
~10% weaker price swings than usual
Ask the agents about Medicus Pharma
Analyst assessment of Medicus Pharma
PRICE TARGET LOW
US$1.00
CONSENSUS
US$1.00
MEDIAN
US$1.00
PRICE TARGET HIGH
US$1.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 20/04/2026
Medicus Pharma stock metrics
P/E
-0.04
P/B
-2.88
EV/EBITDA
-0.23
RETURN ON EQUITY
675.1%
NET MARGIN
0.0%
DEBT/EQUITY
-12.27
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
73.4%
FLOAT SHARES
1,052,197
AVG. DAILY VOLUME (30D)
122,928
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Medicus Pharma stock
What does Medicus Pharma do?
Medicus Pharma Ltd. Common Stock is a company in the Healthcare sector, Biotechnology industry, headquartered in Canada.
The CEO is Raza Bokhari, the company employs around 16 people.
The IPO was on 15/11/2024; the stock trades on NASDAQ under the ticker MDCX.
What do analysts say about Medicus Pharma stock?
2 analysts rate the stock, the consensus is Buy (as of 20/04/2026).
The average price target is US$1.00, ranging from US$1.00 to US$1.00, with a median of US$1.00.
This is an external assessment, not a statement by Market Jury.
When does Medicus Pharma report next?
The next earnings date is 13/11/2026.
Around past earnings, price swings were roughly -10% stronger than usual.
Does Medicus Pharma pay a dividend?
No, Medicus Pharma currently does not pay a dividend.
Which stocks are comparable to Medicus Pharma?
Comparable stocks include AbCellera Biologics, Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines and Incyte.
How can I get Medicus Pharma stock analyzed?
Clicking "Analyze stock" lets five strategies assess Medicus Pharma against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.